News and Analysis Metabomed lands $12.5 mln Metabomed, a cancer metabolism company, has secured $12.5 million in funding. Iris Dorbian - 19 December 2019 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in